FDA approves new generic valsartan to make up for drug shortage

Brasil Notícia Notícia

FDA approves new generic valsartan to make up for drug shortage
Brasil Últimas Notícias,Brasil Manchetes
  • 📰 CNN
  • ⏱ Reading Time:
  • 40 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 95%

The US Food and Drug Administration approved a new generic of valsartan to help relieve the recent shortage of the medicine, which is used to treat high blood pressure

The US Food and Drug Administration approved a new generic of valsartan on Tuesday to help relieve the recent shortage of the medicine, which is used to treat high blood pressure.

Since last summer, the FDA has issued multiple recalls of generic valsartan medications from several manufacturers after discovering that certain lots contained nitrosamine impurities that pose a cancer risk to patients. The FDA discovered impurities in only the generic, not brand-name, valsartan, which is a form of angiotensin II receptor blockers, or ARBs.

Currently, nine out of every 10 prescription drugs dispensed in the United States are generics. Hernandez hopes that wider availability of prescription drug pricing data, including for generic pills, will help patients become aware of those companies seeking to profit from shortages. The case of valsartan may be"very unique," but"drug shortages are a very common phenomenon these days," she said.

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

CNN /  🏆 4. in US

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

CNN questions DNC's decision to block Fox News from hosting Democratic primary debateCNN questions DNC's decision to block Fox News from hosting Democratic primary debate'This has been a long-running problem that Fox has had with the Democratic party, they have viewed them as not a legitimate news organization and they haven't wanted to do debates with them,' USA Today columnist Kristen Powers said.
Consulte Mais informação »

Silicon Valley just lost a friend with the exit of Gottlieb from the FDASilicon Valley just lost a friend with the exit of Gottlieb from the FDASilicon Valley's tech companies like Apple and Alphabet had an ally in FDA commissioner Scott Gottlieb.
Consulte Mais informação »

Birth control recall: Pregnancy risk warning issued by FDA after 'packaging error'Birth control recall: Pregnancy risk warning issued by FDA after 'packaging error'The FDA warned those using the affected drugs to use alternative precautions to prevent pregnancy.
Consulte Mais informação »

John Kasich: It's time for Republicans in Congress to put country over partyJohn Kasich: It's time for Republicans in Congress to put country over partyIt's time for Republicans in Congress to put country over party, writes John Kasich for cnnopinion
Consulte Mais informação »

Several passengers hurt as cruise ship tilts when hit by sudden 115 mph gustSeveral passengers hurt as cruise ship tilts when hit by sudden 115 mph gustSeveral Norwegian Cruise Line passengers were hurt as a cruise ship was hit by a sudden 115 mph wind gust, tilting it and sending bottles crashing off shelves and furniture sliding across the floor
Consulte Mais informação »

Americans can't get enough really expensive liquorAmericans can't get enough really expensive liquorSpirits gained market share compared to beer and wine for the ninth straight year in 2018, according to a national trade organization that represents distilled spirits makers in the US
Consulte Mais informação »

Unemployment a key issue as India's Narendra Modi seeks re-electionUnemployment a key issue as India's Narendra Modi seeks re-electionIndian politicians have already started campaigning for what is shaping up to be a surprisingly unpredictable election
Consulte Mais informação »

Here's how to get on a board of directorsHere's how to get on a board of directorsCNN News, delivered. Select from our newsletters below and enter your email to subscribe.
Consulte Mais informação »



Render Time: 2025-03-03 20:11:00